agilon health, inc. Other Noncash Income (Expense)
agilon health, inc. (AGL) reported Other Noncash Income (Expense) of -$1.38 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2026-08-05
- agilon health, inc. other noncash income (expense) for the quarter ending 2026-06-30 was -$446.00K, a 150.80% decline year-over-year.
- agilon health, inc. other noncash income (expense) for the quarter ending 2026-03-31 was -$931.00K, a 141.77% decline year-over-year.
- agilon health, inc. other noncash income (expense) for the quarter ending 2025-12-31 was -$53.00K.
- agilon health, inc. other noncash income (expense) for the quarter ending 2025-09-30 was $2.46M.
- agilon health, inc. other noncash income (expense) for fiscal 2025 was $5.52M.
- agilon health, inc. other noncash income (expense) for fiscal 2024 was -$887.00K, a 121.93% decline from fiscal 2023.
- agilon health, inc. other noncash income (expense) for fiscal 2023 was $4.04M.
- agilon health, inc. other noncash income (expense) for fiscal 2022 was -$2.97M.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 3 month as first filed | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 6 month as first filed | Other Noncash Income (Expense) 9 month | Other Noncash Income (Expense) 9 month as first filed | Other Noncash Income (Expense) 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$446.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$1.38M 10-Q · filed 2026-08-05 | -$1.43M derived: sum of 3 quarters · filed 2026-08-05 | $1.03M derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2026-03-31 | -$931.00K 10-Q · filed 2026-05-06 | -$984.00K derived: sum of 2 quarters · filed 2026-05-06 | $1.48M derived: sum of 3 quarters · filed 2026-05-06 | $2.36M derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-12-31 | -$53.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $2.41M derived: sum of 2 quarters · filed 2026-02-25 | $3.29M derived: sum of 3 quarters · filed 2026-08-05 | $5.52M 10-K · filed 2026-02-25 | |||
| 2025-09-30 | $2.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $3.34M derived: sum of 2 quarters · filed 2026-08-05 | $5.57M 10-Q · filed 2025-11-04 | $4.19M derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-06-30 | $878.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $3.11M 10-Q · filed 2026-08-05 | $1.73M derived: sum of 3 quarters · filed 2026-08-05 | $1.38M derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-03-31 | $2.23M 10-Q · filed 2026-05-06 | $851.00K derived: sum of 2 quarters · filed 2026-05-06 | $505.00K derived: sum of 3 quarters · filed 2026-05-06 | $870.00K derived: sum of 4 quarters · filed 2026-05-06 | |||
| 2024-12-31 | -$1.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$1.72M derived: sum of 2 quarters · filed 2026-02-25 | -$1.36M derived: sum of 3 quarters · filed 2026-02-25 | -$887.00K 10-K · filed 2026-02-25 | |||
| 2024-09-30 | -$346.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $19.00K derived: sum of 2 quarters · filed 2025-11-04 | $491.00K 10-Q · filed 2025-11-04 | $3.02M derived: sum of 4 quarters · filed 2026-02-25 | |||
| 2024-06-30 | $365.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | $837.00K 10-Q · filed 2025-08-04 | $3.37M derived: sum of 3 quarters · filed 2026-02-25 | $2.56M derived: sum of 4 quarters · filed 2026-02-25 | |||
| 2024-03-31 | $472.00K 10-Q · filed 2025-05-06 | $3.00M derived: sum of 2 quarters · filed 2026-02-25 | $2.19M derived: sum of 3 quarters · filed 2026-02-25 | $2.73M derived: sum of 4 quarters · filed 2026-02-25 | |||
| 2023-12-31 | $2.53M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $1.72M derived: sum of 2 quarters · filed 2026-02-25 | $2.26M derived: sum of 3 quarters · filed 2026-02-25 | $4.04M 10-K · filed 2026-02-25 | |||
| 2023-09-30 | -$811.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$274.00K derived: sum of 2 quarters · filed 2024-11-07 | $1.51M 10-Q · filed 2024-11-07 | $2.80M derived: sum of 4 quarters · filed 2025-02-25 | |||
| 2023-06-30 | $537.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $2.32M 10-Q · filed 2024-08-06 | $3.61M derived: sum of 3 quarters · filed 2025-02-25 | $2.85M derived: sum of 4 quarters · filed 2025-02-25 | |||
| 2023-03-31 | $1.78M 10-Q · filed 2024-05-07 | $3.07M derived: sum of 2 quarters · filed 2025-02-25 | $2.31M derived: sum of 3 quarters · filed 2025-02-25 | -$632.00K derived: sum of 4 quarters · filed 2025-02-25 | |||
| 2022-12-31 | $1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $524.00K derived: sum of 2 quarters · filed 2025-02-25 | -$2.42M derived: sum of 3 quarters · filed 2025-02-25 | -$2.97M 10-K · filed 2025-02-25 | |||
| 2022-09-30 | -$764.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$3.71M derived: sum of 2 quarters · filed 2023-11-02 | -$4.26M 10-Q · filed 2023-11-02 | -$4.21M derived: sum of 4 quarters · filed 2024-02-27 | |||
| 2022-06-30 | -$2.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$3.50M 10-Q · filed 2023-08-03 | -$3.44M derived: sum of 3 quarters · filed 2024-02-27 | -$1.54M derived: sum of 4 quarters · filed 2024-02-27 | |||
| 2022-03-31 | -$556.00K 10-Q · filed 2023-05-09 | -$503.00K derived: sum of 2 quarters · filed 2024-02-27 | $1.40M derived: sum of 3 quarters · filed 2024-02-27 | $1.15M derived: sum of 4 quarters · filed 2024-02-27 | |||
| 2021-12-31 | $53.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $1.95M derived: sum of 2 quarters · filed 2024-02-27 | $1.71M derived: sum of 3 quarters · filed 2024-02-27 | -$58.00K 10-K · filed 2024-02-27 | |||
| 2021-09-30 | $1.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $1.65M derived: sum of 2 quarters · filed 2022-11-03 | -$111.00K 10-Q · filed 2022-11-03 | $111.00K 10-Q · filed 2021-10-28 | -$225.00K derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2021-06-30 | -$248.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$2.01M 10-Q · filed 2022-08-04 | $2.01M 10-Q · filed 2021-08-04 | -$2.13M derived: sum of 3 quarters · filed 2023-03-01 | -$2.37M derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2021-03-31 | -$1.76M 10-Q · filed 2022-05-05 | -$1.77M 10-Q · filed 2021-05-26 | -$1.88M derived: sum of 2 quarters · filed 2023-03-01 | -$2.12M derived: sum of 3 quarters · filed 2023-03-01 | -$764.00K derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2020-12-31 | -$114.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$358.00K derived: sum of 2 quarters · filed 2023-03-01 | $999.00K derived: sum of 3 quarters · filed 2023-03-01 | $162.00K 10-K · filed 2023-03-01 | |||
| 2020-09-30 | -$244.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $1.11M derived: sum of 2 quarters · filed 2021-10-28 | $276.00K 10-Q · filed 2021-10-28 | ||||
| 2020-06-30 | $1.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $520.00K 10-Q · filed 2021-08-04 | |||||
| 2020-03-31 | -$837.00K 10-Q · filed 2021-05-26 | ||||||
| 2019-12-31 | $3.07M 10-K · filed 2022-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |